Fractyl Health (GUTS) Gross Profit (2023 - 2024)
Fractyl Health's (GUTS) quarterly Gross Profit came in at $3000.0 in Q4 2024, down 40.0% YoY from $5000.0 in Q1 2024, and down 57.14% on a QoQ basis from $7000.0 in Q3 2024.
Fractyl Health (GUTS) Gross Profit (2023 - 2024) Analysis & Trends
Fractyl Health (GUTS) has 2 years of Gross Profit data on file, last reported at $3000.0 in Q4 2024.
- Quarterly Gross Profit fell 40.0% year-over-year to $3000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $43000.0 (changed 0.0% YoY) and the FY2024 annual result came in at $43000.0, changed 0.0% from the prior year.
- Gross Profit eased to $3000.0 in Q4 2024, from $7000.0 in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $25000.0 in Q2 2023 to a low of $2000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Fractyl Health | 123.81 Mn | 123.81 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 3,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 7,000.00 |
| Sep 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Jun 30, 2024 | 19,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Mar 31, 2024 | 14,000.00 |
| Dec 31, 2023 | 5,000.00 |
| Dec 31, 2023 | 5,000.00 |
| Sep 30, 2023 | 11,000.00 |
| Sep 30, 2023 | 11,000.00 |
| Jun 30, 2023 | 25,000.00 |
| Jun 30, 2023 | 25,000.00 |
| Mar 31, 2023 | 2,000.00 |
| Mar 31, 2023 | 2,000.00 |